Fox Run Management L.L.C. Purchases New Stake in Plexus Corp. (NASDAQ:PLXS)

Fox Run Management L.L.C. purchased a new position in Plexus Corp. (NASDAQ:PLXS) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,882 shares of the technology company’s stock, valued at approximately $294,000.

A number of other hedge funds have also recently modified their holdings of the company. TD Private Client Wealth LLC purchased a new position in Plexus during the 4th quarter valued at about $28,000. Quarry LP increased its stake in shares of Plexus by 573.5% during the third quarter. Quarry LP now owns 229 shares of the technology company’s stock valued at $31,000 after buying an additional 195 shares during the period. R Squared Ltd purchased a new position in shares of Plexus during the fourth quarter valued at approximately $45,000. Point72 DIFC Ltd bought a new position in shares of Plexus during the third quarter valued at approximately $51,000. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in Plexus in the third quarter worth $55,000. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on PLXS. Benchmark reaffirmed a “buy” rating and issued a $165.00 target price on shares of Plexus in a research report on Wednesday, January 22nd. Stifel Nicolaus began coverage on shares of Plexus in a report on Tuesday, February 4th. They issued a “hold” rating and a $152.00 price objective for the company. Finally, Needham & Company LLC upped their target price on Plexus from $162.00 to $172.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Plexus presently has an average rating of “Moderate Buy” and an average target price of $163.00.

Insiders Place Their Bets

In other Plexus news, CFO Patrick John Jermain sold 3,361 shares of the stock in a transaction on Monday, January 27th. The stock was sold at an average price of $144.57, for a total transaction of $485,899.77. Following the sale, the chief financial officer now directly owns 20,745 shares in the company, valued at approximately $2,999,104.65. This trade represents a 13.94 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Todd P. Kelsey sold 1,500 shares of the business’s stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $136.96, for a total value of $205,440.00. Following the completion of the transaction, the chief executive officer now owns 86,932 shares of the company’s stock, valued at $11,906,206.72. This represents a 1.70 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 19,458 shares of company stock valued at $2,786,515. Insiders own 1.76% of the company’s stock.

Plexus Trading Down 0.2 %

Shares of NASDAQ PLXS opened at $129.99 on Friday. Plexus Corp. has a 1 year low of $92.72 and a 1 year high of $172.89. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.53 and a quick ratio of 0.70. The firm has a 50-day moving average of $137.39 and a 200 day moving average of $145.65. The stock has a market cap of $3.51 billion, a P/E ratio of 30.16 and a beta of 0.90.

Plexus (NASDAQ:PLXS) last released its earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a net margin of 3.03% and a return on equity of 10.36%. As a group, sell-side analysts expect that Plexus Corp. will post 5.9 EPS for the current fiscal year.

Plexus Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.